cap-dependent translation inhibitors (Novomedix)

N/A

Report date: 2025/06/11 10:25:00
NME

Base Information

Drug Namecap-dependent translation inhibitors (Novomedix)
Drug Alias NameNM-043NM-891NM-768NM-922
ClassificationSmall molecules
Mechanisms of ActionTranslation pathway modulators
TargetsUpdating
Therapy Area/IndicationsHeart FailureTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNovomedix LLC
China Registration ClassN/A

Develop Information

Active CompaniesNovomedix LLC
Inactive CompaniesN/A
Active IndicationsHeart FailureTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A